Search the Newsreel

Ohio Valley Banc Corp. Reports 2nd Quarter Earnings

Ohio Valley Banc Corp. (OVBC) reported a significant decrease in second-quarter net income for 2026, falling by 30.5% to $2.9 million, primarily due to an increased provision for credit losses related to a few large commercial credits. Despite this, net interest income grew, driven …

Celebrity Fashions Limited Revenue Breakdown – NSE:CELEBRITY

Ohio Valley Banc Corp (OVBC) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides a detailed historical timeline of dividend payouts for Ohio Valley Banc Corp (OVBC), including interim and final cash dividends. It lists the dividend amount, record date, payment date, and ex-dividend date for each payout. The company has distributed a total of …

Phio Pharmaceuticals Corp (PHIO) Balance Sheet

This page provides a detailed balance sheet for Phio Pharmaceuticals Corp (PHIO), offering both quarterly and annual data for evaluating the company's financial health. It includes key financial metrics such as cash and short-term investments, total assets, current assets, liabilities, and shareholders' equity, along …

Ohio Valley Banc Corp (OVBC) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides an incomplete revenue breakdown for Ohio Valley Banc Corp (OVBC). While it lists a total revenue of $59.70 million attributed to the United States, it states that detailed segment and regional breakdown data for recent fiscal years (FY2025, FY2024) has not …

Lulu's Fashion Lounge Holdings Inc (LVLU) Cash Flow Statement

This article provides a detailed cash flow statement for Lulu's Fashion Lounge Holdings Inc (LVLU), covering quarterly and annual data from FY2026Q1 back to FY2020Q3. It outlines operational, investing, and financing cash flows, including net income, capital expenditures, and debt activities. The report also …

Lulu's Fashion Lounge Holdings, Inc. (NASDAQ:LVLU) Short Interest Update

Phio Pharmaceuticals Corp (PHIO) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Phio Pharmaceuticals Corp (PHIO), detailing its price momentum, support and resistance levels, and various technical indicators and moving averages. PHIO currently has a price momentum score of 4.96, ranking 142nd in its industry, trading between a resistance …

Monte Carlo Fashions Q1 Results: Earnings call scheduled for August 6

Vedant Fashions Q1 net profit rises 15% on higher sales; Ravi Modi reappointed CMD

Phio Pharmaceuticals Corp. Revenue Breakdown – NASDAQ:PHIO

This article provides a link to Phio Pharmaceuticals Corp.'s (NASDAQ: PHIO) revenue breakdown on TradingView. It indicates that the market was closed at the time of viewing and offers various financial and analytical tools for the company. The page also includes general information about …

Press Release: ParkOhio Announces Second Quarter 2026 Results Webcast

ParkOhio (NASDAQ: PKOH) is scheduled to release its second-quarter 2026 financial results after the market closes on Tuesday, August 4, 2026. The company will host a conference call and webcast on Wednesday, August 5, 2026, at 10:00 AM ET to discuss the results. Interested …

PHIO|Phio Pharmaceuticals Corp|Price:1.010|

Phio Pharmaceuticals Corp (PHIO) is a clinical-stage biotechnology company focused on developing therapeutics for cancer treatment using its INTASYL self-delivering RNAi technology. The company's pipeline includes PH-762 and PH-894, targeting PD-1 and BRD4 respectively, to enhance the immune system's ability to fight tumors. The …

PHIO|Phio Pharmaceuticals Corp|Price:1.075|Chg%:+0.015

Phio Pharmaceuticals Corp (PHIO) exhibits relatively healthy fundamentals and high growth potential, though its valuation is considered fair within the Biotechnology & Medical Research industry. Despite a positive stock market performance and strong fundamentals recently, technical analysis suggests a possible downward trend in the …

Arvind Fashions Limited (NSE:ARVINDFASN) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

Lulu's Fashion Lounge Holdings Inc (LVLU) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Lulu's Fashion Lounge Holdings Inc (LVLU), examining its price momentum, support and resistance levels, and various technical indicators and moving averages. The current price momentum score is 7.44, and the stock is trading between resistance at $23.55 …

ParkOhio to Stream Second-Quarter Results Live Aug. 6

ParkOhio (NASDAQ: PKOH) announced that it will host a webcast for its Second Quarter 2026 financial results conference call on Thursday, August 6, 2026, at 9:00 a.m. Eastern Time. The live webcast will be accessible online, and an archive will be available on the …

Go Fashion (India) Limited to host Q1 FY27 earnings call on July 30

Lulus to Report Second Quarter 2026 Results on August 12, 2026

Lulu's Fashion Lounge Holdings, Inc. (Lulus) announced it will release its second quarter 2026 financial results on Wednesday, August 12, 2026, after market close. The company will host a conference call and live webcast for the investment community at 5:00 p.m. Eastern Time on …

Phio Pharmaceuticals to present its INTASYL siR...

Phio Pharmaceuticals will present its INTASYL siRNA gene silencing technology and lead cancer drug PH-762 on July 28, 2026, during a virtual non-deal roadshow. CEO Robert Bitterman will discuss PH-762, which is designed to silence the PD-1 gene to enhance the immune response against …

Correction to Announcement Regarding Phio Pharmaceuticals Participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series

Phio Pharmaceuticals Corp. has issued a correction regarding its participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series. The company's CEO, Robert Bitterman, will present an overview of their INTASYL® siRNA platform, including the lead clinical candidate PH-762 for cutaneous carcinomas, followed …

Lulus will webcast second-quarter results after market close

Lulus (Nasdaq: LVLU) announced it will release its second-quarter 2026 financial results on Wednesday, August 12, 2026, after market close. The company will host a conference call and live webcast with investors at 5:00 p.m. Eastern Time, accessible via its Investor Relations website. Previous …

Vedant Fashions to host Q1FY27 earnings call on July 27

Shore Capital Group Reaffirms Hold Rating for JD Sports Fashion (LON:JD)

Park-Ohio Holdings Corp To Go Ex-Dividend On July 31st, 2026 With 0.125 USD Dividend Per Share

Park-Ohio Holdings Corp is scheduled to go ex-dividend on July 31st, 2026. The company will pay a dividend of 0.125 USD per share to shareholders. Investors wishing to receive this dividend must own shares before the ex-dividend date.

Park-Ohio (NASDAQ:PKOH) Hits New 12-Month High - What's Next?

Park-Ohio (NASDAQ:PKOH) reached a new 52-week high, trading at $39.41 after a 5.8% gain, with significant trading volume. This surge follows strong fundamentals, including meeting EPS expectations and exceeding revenue estimates, alongside a declared quarterly dividend of $0.125 per share. Analyst ratings are mixed …

Phio Pharmaceuticals appoints dermatologist to board By Investing.com

Phio Pharmaceuticals Corp. has appointed R. Todd Plott, M.D., a board-certified dermatologist with over 30 years of experience, to its Board of Directors. Plott's expertise in dermatologic care and clinical development will aid the company in advancing its PH-762 therapeutic for squamous cell carcinoma, …

Phio Pharmaceuticals adds R. Todd Plott to its Board, joins Governance Committee

Phio Pharmaceuticals has announced the appointment of R. Todd Plott, M.D., to its Board of Directors, effective July 20, 2026. Dr. Plott will also serve as a member of the Governance Committee. He brings over 30 years of experience in dermatologic care and innovation, …

More Than 30 Years in Dermatology: Phio Adds a Director

Phio Pharmaceuticals has appointed Dr. R. Todd Plott, a board-certified dermatologist and former FDA advisory committee member with over 30 years of experience, to its Board of Directors. Dr. Plott's extensive background in dermatologic care, clinical research, drug development, and overseeing hundreds of clinical …

Phio Pharmaceuticals Announces Appointment of Dr. R. Todd Plott to the Board of Directors

Phio Pharmaceuticals has appointed Dr. R. Todd Plott, an experienced dermatologist and researcher, to its Board of Directors. Dr. Plott brings over 30 years of experience in dermatologic care, clinical development, and as a former FDA advisory committee member, which will be a valuable …

Arvind Fashions Q1 revenue rises 15.5% to ₹1,279 crore

Arvind Fashions Q1 Results: Net profit rises 11% to Rs 27.61 cr

Arvind Fashions Q1 Revenue Rises 15.5 Pc to Rs 1,278.5 Cr

Arvind Fashions Q1 Results: Net profit rises 11%, revenue climbs 16%

Phio Pharmaceuticals Announces Patent Milestone with Multiple Notices of Allowance and Grant Decision

Phio Pharmaceuticals Corp. announced significant progress in protecting its proprietary INTASYL® gene silencing technology, securing multiple favorable patent actions including three notices of allowance and one grant decision in the United States, Canada, and Japan. This strengthens the company's global intellectual property portfolio for …

OVBC announces new CEO, special dividend

OVBC announced a new CEO and a special dividend. The announcement was made via PRNewswire on May 19, 2022. This news is relevant for investors tracking company leadership changes and dividend payouts.